Discontinued — last reported Q4 '25
Year-over-year, this metric grew by 7.1%, from $70.00M to $75.00M.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $89.90M | $0.00 | $15.00M | $35.00M | $10.10M | $0.00 | $45.00M | $30.10M | $150.00M | $0.00 | $40.00M | $70.00M | $70.00M | $250.00M | $150.00M | $0.00 | $75.00M |
| QoQ Change | — | — | — | — | -100.0% | — | +133.3% | -71.1% | -100.0% | — | -33.1% | +398.3% | -100.0% | — | +75.0% | +0.0% | +257.1% | -40.0% | -100.0% | — |
| YoY Change | — | — | — | — | — | — | — | -88.8% | — | +200.0% | -14.0% | >999% | — | -11.1% | +132.6% | -53.3% | — | +275.0% | -100.0% | +7.1% |